Rinvoq is prescribed for several inflammatory conditions, including rheumatoid arthritis and eczema. If you’re considering it, you might wonder if it will affect your weight.
Rinvoq can cause weight gain in some people, but it’s typically mild and not everyone experiences it. Clinical studies show about 5% of patients notice weight gain, while most see little to no change.
The connection between Rinvoq and weight is nuanced. Factors include the medication’s action, the condition being treated, and individual response.
It’s also important to consider whether weight changes come from the medication or from improved inflammation control.
Does Rinvoq Cause Weight Gain?
Rinvoq (upadacitinib) can cause weight gain in some patients. The risk varies by the condition being treated.
Weight gain appears more often in people taking Rinvoq for atopic dermatitis than for rheumatoid arthritis.
How Common Is Weight Gain With Rinvoq?
Weight gain occurs in 1-10% of patients taking Rinvoq, making it a common side effect in clinical trials. Frequency differs by condition, with atopic dermatitis patients reporting it more often than those with rheumatoid arthritis.
FDA reports from 47,330 Rinvoq users found only 10 people (0.02%) specifically reported abnormal weight gain. This suggests real-world occurrence may be lower than initial trial data.
Most patients who do gain weight report modest increases. Many maintain stable weight throughout treatment.
Who Is Most Likely To Experience Weight Gain?
Certain groups are more likely to report weight gain with Rinvoq:
- Males: 60% of cases
- Age: 50-59 and 60+ each account for 33% of cases
- Treatment duration: Most cases appear between 1-12 months of use
- Concurrent medications: Higher rates in those also taking Kevzara, Humira, or Orencia
Rheumatoid arthritis patients represent 70% of weight gain cases, likely reflecting the larger user base. Crohn’s disease accounts for 20%. Pre-existing hypothyroidism may also increase risk.
Severity and Pattern of Weight Changes
Weight gain with Rinvoq is generally mild and gradual. Sudden, dramatic increases are rare.
The effect is partly due to inflammation control—chronic inflammation can cause muscle wasting and weight loss. When Rinvoq reduces inflammation, patients may regain weight naturally.
Weight changes usually appear between one and twelve months of treatment. No cases have been reported beyond a year, suggesting the effect levels off over time.
Patients with psoriatic arthritis, ulcerative colitis, or Crohn’s disease may gain weight as digestive symptoms improve and nutrient absorption normalizes. In these cases, weight gain can signal improved health.
Why Rinvoq Might Lead To Weight Gain
Rinvoq alters inflammatory pathways and metabolic processes as a JAK inhibitor. Its effects go beyond symptom relief, influencing fluid retention and energy processing.
Role of Inflammation Control in Weight Regulation
Rinvoq blocks Janus kinases, reducing inflammation in conditions like rheumatoid arthritis and atopic dermatitis. Chronic inflammation suppresses appetite and increases metabolic rate.
When Rinvoq eases inflammation, appetite is restored. Patients often eat more as their symptoms improve.
Atopic dermatitis trials showed some weight gain, while rheumatoid arthritis studies reported minimal changes. This suggests the impact varies by condition.
Improved symptoms can result in a return to normal eating habits. If activity doesn’t increase alongside appetite, weight gain can occur.
Metabolic Effects of JAK Inhibitors
JAK inhibitors like upadacitinib affect cellular signals that regulate fats and carbohydrates. They may:
- Alter lipid metabolism
- Affect glucose regulation and insulin sensitivity
- Modify energy expenditure
These changes can slow metabolic rate in some people, making weight gain easier. The effect is more pronounced in those also taking corticosteroids.
Fluid Retention vs. Fat Accumulation
Weight gain on Rinvoq can result from fluid retention or fat accumulation.
Fluid retention is marked by swelling, rapid weight gain, and puffiness. Fat accumulation is gradual, with changes in body composition and waist size.
Phase IV data show 1.21% of patients reported weight increases, often due to fluid retention. JAK inhibitors can affect kidney function and fluid balance, though this is rare.
Rapid weight gain over a week suggests fluid retention and should be evaluated. Slower, steady gains are more likely due to metabolic changes or increased appetite.
Comparing Rinvoq With Other Medications
Weight gain patterns differ across treatments for arthritis and inflammatory diseases.
Rinvoq vs. Other JAK Inhibitors
Rinvoq is part of the JAK inhibitor class, alongside Xeljanz and Olumiant. About 2% of atopic dermatitis patients report weight gain with Rinvoq.
Xeljanz and Olumiant show similar effects, as all block JAK pathways involved in inflammation and metabolism.
- Rinvoq targets JAK1
- Xeljanz targets JAK1 and JAK3
- Olumiant targets JAK1 and JAK2
These differences may influence metabolic effects, but more research is needed.
Rinvoq vs. Biologic Agents
Biologics like Humira, Enbrel, and Remicade target specific proteins, not intracellular pathways. Rinvoq did not cause weight gain in rheumatoid arthritis trials, and biologics generally have little direct effect on weight.
Reduced inflammation from either class can lead to “improvement-related” weight gain, as patients eat and move more normally.
Humira and Rinvoq show similar patterns: less disease activity often means some weight gain, but neither consistently causes dramatic changes.
Role of Corticosteroids and NSAIDs in Weight Change
Corticosteroids like prednisone pose the greatest weight gain risk, especially when combined with Rinvoq. They cause fluid retention and increased appetite.
NSAIDs such as naproxen and ibuprofen can cause temporary water weight through fluid retention.
| Medication Type | Primary Weight Effect | Severity |
|---|---|---|
| Corticosteroids (prednisone) | Fluid retention + fat gain | High |
| NSAIDs (ibuprofen, naproxen) | Fluid retention | Moderate |
| DMARDs (azathioprine) | Minimal direct effect | Low |
Distinguishing Rinvoq’s impact from corticosteroid use is key for accurate assessment.
Managing and Preventing Weight Gain on Rinvoq
Most patients won’t gain significant weight on Rinvoq, but healthy habits can help manage this side effect.
Healthy Diet Recommendations
An anti-inflammatory diet like the Mediterranean diet supports weight management and reduces inflammation. Focus on whole grains, lean proteins, fruits, vegetables, and healthy fats.
Limit processed foods, excess sugar, and refined carbs. Choose nutrient-dense options.
Consider working with a registered dietitian for personalized advice, especially if you take corticosteroids.
Physical Activity Guidelines
Regular exercise helps control weight and reduces inflammation. Aim for moderate activities like walking, swimming, or cycling for 30 minutes most days.
Strength training twice a week builds muscle and boosts metabolism. Low-impact exercises are ideal for those with joint pain.
On low-energy days, lighter activities like stretching or yoga still provide benefits. Consistency is more important than intensity—sustainable routines are key.
Monitoring Weight and Side Effects
Track your weight weekly at the same time of day to spot trends early. Document changes alongside symptoms like headache, nausea, or acne to give your healthcare provider a full picture.
Schedule regular check-ins with your doctor to review how Rinvoq affects your health. They may adjust your dosage or suggest alternatives if weight gain becomes an issue.
Keep a symptom journal noting both benefits and side effects. This helps differentiate medication-related weight changes from those due to increased activity as inflammation subsides.
Report significant weight increases or concerning symptoms promptly, rather than waiting for your next appointment. Early intervention can prevent minor issues from becoming major problems.
Other Side Effects and Safety Concerns
Rinvoq carries several risks beyond weight gain that require close monitoring. The drug can suppress immune function, increase clotting risks, and alter blood cell counts, necessitating ongoing medical supervision.
Infections and Immunosuppression Risks
Rinvoq lowers the body’s ability to fight infections by suppressing immune activity. While this controls inflammation, it can also lead to serious infections.
Tuberculosis (TB) is a significant risk. Patients are tested for TB before starting Rinvoq and monitored for symptoms during treatment. Active infections must be resolved before beginning therapy.
Upper respiratory tract infections—like colds, sinus infections, and bronchitis—are common. They are usually mild but can progress in some patients.
Shingles (herpes zoster) occurs more frequently in Rinvoq users, as does herpes simplex (cold sores). The chickenpox virus can reactivate, causing painful rashes and nerve pain.
Pneumonia has been reported, sometimes severely, especially in older adults or those with other health conditions. Symptoms like persistent cough, fever, or difficulty breathing require immediate attention.
Blood Clots and Cardiovascular Events
Blood clots in veins and arteries are life-threatening complications that can occur with Rinvoq. The risk is higher in people over 50 with cardiovascular risk factors.
Thrombosis can develop in the deep veins of the legs, causing swelling, pain, and tenderness. Clots can travel to the lungs, leading to pulmonary embolism—marked by sudden chest pain and shortness of breath—which requires urgent treatment.
Cardiovascular events such as heart attack and stroke occur more often in Rinvoq users, particularly among current or former smokers. Warning signs include chest discomfort, pain radiating to the arms or jaw, weakness on one side, and slurred speech.
The prescribing information includes a boxed warning about increased death risk in people over 50 with cardiovascular risk factors. Patients should discuss their risk profile with their healthcare provider before starting Rinvoq.
Long-Term Safety and Cancer Risks
Rinvoq may increase the risk of certain cancers, especially with long-term use. Immune suppression reduces inflammation but also impairs the body’s ability to detect abnormal cells.
Lymphoma and other immune system cancers have occurred in patients taking Rinvoq. Current or former smokers face higher risks for lymphoma and lung cancer.
Skin cancers—both melanoma and non-melanoma—are reported more often in Rinvoq users. Patients are advised to limit sun exposure, wear protective clothing, use sunscreen, and have regular skin checks.
Those with a personal cancer history need careful evaluation before starting Rinvoq. The decision involves weighing symptom control benefits against potential cancer risks.
Decreased Blood Counts and Cholesterol Issues
Rinvoq can affect blood cell production and lipid metabolism, requiring regular lab monitoring.
Decreased white blood cells (neutropenia, lymphopenia, leukopenia) are common, increasing infection risk. Blood counts are checked before and during treatment.
Anemia may develop, leading to fatigue, weakness, and shortness of breath. Dose adjustments or treatment breaks may be needed.
High cholesterol is another effect, with increased LDL and total cholesterol seen in blood tests. Some patients require cholesterol-lowering medications.
Gastrointestinal perforation (tears in the stomach or intestines) can occur, especially in those taking NSAIDs or corticosteroids. Sudden abdominal pain, fever, or vomiting require urgent evaluation. Liver enzyme elevations may also necessitate dosing changes.
Rinvoq for Different Conditions: Weighing the Benefits
Rinvoq’s impact on weight varies by condition. Atopic dermatitis patients experience weight changes more often than those with arthritis or inflammatory bowel disease. The drug’s effectiveness and risk profile differ across these conditions.
Rheumatoid Arthritis and Weight Change
Weight gain is less common in rheumatoid arthritis patients on Rinvoq, with clinical trials showing about 2% experience increased weight.
Rinvoq blocks JAK enzymes to reduce joint inflammation, pain, and disease progression. For most RA patients, the benefits outweigh weight concerns, especially since joint function and quality of life can improve.
Some patients also take NSAIDs or corticosteroids, which may independently contribute to weight changes.
Atopic Dermatitis and Eczema Cases
Weight gain is more frequent in atopic dermatitis patients, with the FDA reporting it in 1-10% of cases.
The reason for this increase is unclear, but appetite or metabolic changes may play a role. Corticosteroids taken alongside Rinvoq can add to weight gain.
Some weight gain may signal recovery, as improved eczema allows patients to regain lost muscle and strength. It’s important to distinguish between healthy recovery and excessive fat accumulation.
Key considerations for eczema patients:
- Monitor weight regularly
- Discuss other medications affecting weight
- Track whether weight gain is muscle or fat
Inflammatory Bowel Diseases: Crohn’s and Ulcerative Colitis
Rinvoq treats Crohn’s disease and ulcerative colitis by reducing intestinal inflammation. Weight changes in these patients are complex, as IBD often causes weight loss.
Some weight gain may indicate treatment success, reflecting improved nutrient absorption and appetite. Providers must distinguish between healthy weight restoration and problematic increases.
For IBD, achieving remission and preventing complications usually takes priority over weight concerns. Regular monitoring ensures weight changes remain healthy.
Nonradiographic Axial Spondyloarthritis and Ankylosing Spondylitis
These spine conditions respond well to Rinvoq, with minimal reported weight gain. The drug reduces inflammation in the spine and sacroiliac joints, improving mobility and decreasing pain.
Obesity can worsen inflammation, so weight management is crucial. Anti-inflammatory diets, such as the Mediterranean diet, and regular exercise are recommended alongside Rinvoq.
Improved mobility from treatment can make exercise easier, supporting weight management and further reducing inflammation.
Practical Tips: Talking With Your Healthcare Provider
Open communication with your doctor helps manage weight changes and ensures Rinvoq remains effective. Tracking details and knowing when to speak up makes appointments more productive.
What to Track and Discuss at Appointments
Keep a weekly log of your weight, measured at the same time of day. Note patterns and symptoms like appetite changes, fluid retention, or energy shifts.
Bring this log to appointments along with notes on diet and activity. Your doctor can help distinguish between weight gain from healing, medication effects, or other factors.
Ask questions such as:
- Is this weight gain expected with Rinvoq?
- Could other medications be responsible?
- Should we adjust the dosage or timing?
Report rapid changes (over 5 pounds in a month) or new symptoms like shortness of breath or swelling. These may signal blood clots or cardiovascular events and require immediate attention.
When to Consider Changing Medications
Weight gain alone rarely warrants stopping Rinvoq if it’s effectively controlling your condition. However, alternatives should be considered if side effects significantly impact your quality of life or health.
Discuss concerns if weight gain worsens other health issues like diabetes or heart disease. Your doctor can suggest alternative treatments with different side effect profiles.
Remember, Rinvoq’s half-life means it takes time to fully clear from your system, so switching medications requires careful planning and monitoring.
Accessing Patient Assistance and Support
The Rinvoq Patient Assistance Program offers financial support and resources for eligible patients. Contact the manufacturer directly if medication costs are a barrier.
Your rheumatologist’s office can connect you with nutritionists familiar with inflammatory conditions. Physical therapists are also available to develop safe exercise programs.
Patient support groups provide a space to share experiences with JAK inhibitors. Many insurance plans cover nutritional counseling when prescribed for medication side effects.
Ask your care team about referrals and coverage options tailored to your needs.
